From left to right: Ms. Becca deDufour (BSN, RN, CCRN, Memorial Sloan Kettering Cancer Center), Nurse Grace NTIMEU KEPNDEP (Lead ICU Nurse, Mbingo Baptist Hospital), Dr. David Sunday (Lead ICU Physician, Mbingo Baptist Hospital), Ms. Joanna Tomicich (DNP, NP-C, AGACNP-BC, FCCM, Memorial Sloan Kettering Cancer Center) Recognizing that the Intensive Care Unit (ICU) nursing teamContinue reading “Cameroon ICU Nursing Team Engages in Virtual Mentorship”
Author Archives: bvghseattle
Researchers in Germany and Nigeria Join Forces to Differentiate Febrile Diseases with New Diagnostics
In sub-Saharan Africa and other regions with high burdens of malaria, patients presenting with fevers are often prescribed antimalarial drugs without a confirmed diagnosis to avoid treatment delays. However, many infectious diseases cause fevers, and inappropriate use of antimalarial medicines for patients who do not have malaria fuels development of drug resistance. While malaria diagnosticContinue reading “Researchers in Germany and Nigeria Join Forces to Differentiate Febrile Diseases with New Diagnostics”
Network for Africa’s Clinical Trials Community Established
BVGH is thrilled to be part of the Clinical Trials Community Africa Network project, a bold step towards a coordinated and sustainable clinical trials network in Africa. This joint effort with Global Health EDCTP; Science for Africa Foundation; Fondation Mérieux; Medicines Development for Global Health; The Janssen Pharmaceutical Companies of Johnson & Johnson; and nuvoteQ.io aims to amplify the capacity of African trial sites and laboratories, while providing essential data and regulatory information through the Clinical Trials Community platform. Together, we can bring life-changing treatments to those who need them most. BVGH will support site and laboratory network development; coordinate and implement capacity building programs; and develop and disseminate targeted communications materials to raise visibility.
NSIA and Nigeria to improve treatment for Nigerians through the building of new cancer centres [EXTERNAL VIDEO]
In this interview with eCancer, the CEO of the Nigeria Sovereign Investment Authority (NSIA), Aminu Umar-Sadiq, discusses the work of NSIA with building new cancer centers in Nigeria. Watch the video here.
Two-day lecture series teaches African care providers best practices in cancer pain management
More than 80% of all cancer patients in Africa present to their local health facility with advanced disease. As cancer progresses into later disease stages, it is frequently accompanied by pain caused by the tumor’s disruption of normal tissue processes. Despite the significant burden of advanced disease, as described in the 2022 Lancet Oncology CommissionContinue reading “Two-day lecture series teaches African care providers best practices in cancer pain management”
Cervical cancer program builds clinical capacity in southern district of Rwanda
Cervical cancer can be eliminated through vaccination, screening, and early treatment, yet it is still the most common cause of cancer deaths among women in sub-Saharan Africa. In an effort to combat the devastating effects of this disease, the First Lady of Rwanda, Madam Jeanette Kagame, tasked BVGH and the Rwandan Biomedical Center (RBC) withContinue reading “Cervical cancer program builds clinical capacity in southern district of Rwanda”
Nigerian radiation oncology center launches advanced radiotherapy service
Based in Lagos, Nigeria, the NSIA-LUTH Cancer Center (NLCC) is one of three Nigerian facilities offering radiation therapy. Funded by the Nigerian Sovereign Investment Authority (NSIA), NLCC is built upon a foundation of partnership and is committed to offering cancer patients cutting-edge care. The center, which opened in 2019, has treated more than 5,000 cancerContinue reading “Nigerian radiation oncology center launches advanced radiotherapy service”
Clinical trial training program addresses cancer data gap in Africa and enables new research ventures for African clinicians
Africa has historically been overlooked by the international oncology research community, resulting in the continent’s participation in less than 2% of all cancer clinical trials. Africa’s underrepresentation in cancer clinical trials has culminated in an alarming lack of data describing the effects of new cancer technologies and treatments in the world’s most genetically diverse population.Continue reading “Clinical trial training program addresses cancer data gap in Africa and enables new research ventures for African clinicians”
Pathologists launch new diagnostic services for cancer patients in southern Rwanda
Opened in 1928, the University Teaching Hospital of Butaré (CHUB) in the Southern Province of Rwanda is one of five major medical facilities in the country that diagnoses cancer. While CHUB can perform basic histology and cytology procedures to diagnose cancers, it has been unable to afford the reagents needed to perform immunohistochemistry (IHC) staining.Continue reading “Pathologists launch new diagnostic services for cancer patients in southern Rwanda”
AC3T Study Pool Mini-Grants empower early-career cancer researchers
Despite representing 4% of the world’s new cancer cases in 2020, only 0.5% of cancer clinical trials have been performed in sub-Saharan Africa. Several factors, including the continent’s limited number of experienced clinical researchers, have contributed to Africa’s underrepresentation in clinical trials. Given the continent’s predicted increase in new cancer cases over the next twoContinue reading “AC3T Study Pool Mini-Grants empower early-career cancer researchers”